物性試験解析の標準化と自動化による抗体候補の開発可能性評価の加速
二重特異性抗体のハイスループットな作製・設計・生産・評価
バイオ医薬品におけるスクランブルジスルフィド結合の自動かつ堅牢な同定
Maximize ROI by 11x with In-House NGS
GMP-Validated. NGS Solutions. In-House.
How Is Automation Transforming Biomarker Discovery?
November 25, 2025
Accelerating Precision Medicine: Using AI Assistants in GxP Environments
Lessons Learned from a Global Genedata Deployment: Impact on Automation, Novel Modalities, and AI/ML
Image Analysis with Machine Learning (ML) at Arvinas
Data, Data in the Well: Who’s the FAIRest of them all? A Tale of In Vitro Characterization of Biologics Preparing for the AI Era
Do The Math: The Unrealized ROI In Lab Automation
Jana Hersch November 14, 2025
統合デジタルプラットフォームによる高分子創薬の推進
mAbs November 12, 2025
NGS in GMP Manufacturing: Reducing Risk, Increasing Return
Christoph Bredack November 6, 2025
How Can Data Translation Challenges in Biopharma–CRO Partnerships Be Overcome?
November 6, 2025
Accelerating High-Content Imaging Analysis with Automation
November 4, 2025
Unsupervised Phenotype Discovery in High-Content Imaging via Archetypes and Self-Supervised Learning
Agentic AI Enables Automated CellProfiler Pipeline Design via Multimodal In-Context Learning
Automated Analysis of High-Throughput Protein Stability For Antibody Developability Assessment
Automated & Scalable MS Analytics for Biotherapeutic Developability
October 14, 2025
Transforming Biopharmaceutical Development through MS Analytics
Digitalizing CMC Processes at Novartis
Efficient NPD Workflow for LC-MS Peptide Mapping in MAM
mAbs October 13, 2025
Novartis Accelerates IND Timelines by Digitalizing CMC Processes
End-to-End Sample Management Solution
Enhancing Gene Therapy Assets with GMP-Ready NGS Assays
バイオ医薬品開発を支える質量分析とデータ解析技術基盤
Workflow Automation for High-Throughput Spectral Shift Analysis
多様なモダリティに対応した統合データ管理の実現
Industry Experiences in Bringing NGS-Based Workflows In-House
Alison Waterfield September 29, 2025
Rapid Contamination Identification with Nanopore Sequencing
Automating Adventitious Agent Detection for GMP and Lot Release
NGS-Powered CMC Strategies
GMP-Ready NGS Platform for mRNA Therapeutics
Genedata Selector
Advancing CNS Therapeutics with Proteomics
Ada Yee, Benjamin Thomas September 11, 2025
Merck EMD社、医薬品候補選定におけるDMTAサイクルの加速
Improving RAS Inhibitor Efficacy by Enabling Biomarker-Driven Decisions
Powering HT Protein Expression and Purification
Pfizer社、共有結合型阻害剤探索のためのマルチプレックスプラットフォーム
Democratizing NGS Analysis for Cell Line Development
AI/MLによる創薬の加速
